First Tracks Biotherapeutics Announces Participation in September Investor Conferences

Rhea-AI Summary

First Tracks Biotherapeutics (Nasdaq: TRAX) will participate in three investor conferences in September 2026: the Wells Fargo Healthcare Conference on September 9 (fireside chat and 1x1s), Citi's Biopharma Back to School Conference on September 10 (1x1s), and the Morgan Stanley Global Healthcare Conference on September 16 (1x1s). A live webcast and 30-day replay of the Wells Fargo fireside chat will be available on the company's investor website.

Market Context

TRAX's short-interest signal was classified as moderate, adding a positioning-risk lens to this conf...

Analysis

TRAX's short-interest signal was classified as moderate, adding a positioning-risk lens to this conference schedule. The notice provides event logistics rather than operating results; subsequent clinical and financial disclosures remain separate information to monitor.

Key Figures

Wells Fargo conference edition: 21st Annual Fireside chat date: Sept. 9, 2026 Fireside chat time: 9:30am ET / 6:30am PT +4 more

7 metrics

Wells Fargo conference edition 21st Annual Healthcare Conference

Fireside chat date Sept. 9, 2026 Wells Fargo Healthcare Conference

Fireside chat time 9:30am ET / 6:30am PT Wells Fargo Healthcare Conference

Citi conference date Sept. 10, 2026 Citi's 2026 Biopharma Back to School Conference

Morgan Stanley conference edition 24th Annual Global Healthcare Conference

Morgan Stanley conference date Sept. 16, 2026 Morgan Stanley Global Healthcare Conference

Webcast replay availability at least 30 days Following the event

Historical Context

3 past events · Latest: Aug 12 (Neutral)

Pattern 3 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 12	Q2 earnings report	Neutral	-4.5%	Reported quarterly results, pipeline progress, and reiterated cash runway into Q2 2028
May 21	Conference participation	Neutral	+2.5%	Announced participation in Jefferies and Leerink Partners investor events
May 14	Q1 earnings report	Negative	-6.9%	Reported quarterly net loss and ongoing clinical development programs

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

TRAX's two recent earnings-related announcements were followed by negative 24-hour reactions, while its prior conference notice was followed by a positive reaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences:

21^st Annual Wells Fargo Healthcare Conference, Boston

• Format – Fireside chat and one-on-one investor meetings
• Date and Time – Wednesday, Sept. 9, 2026 at 9:30am ET / 6:30am PT

Citi's 2026 Biopharma Back to School Conference, New York City

• Format – One-on-one investor meetings
• Date and Time – Thursday, Sept. 10, 2026

Morgan Stanley 24th Annual Global Healthcare Conference, New York City

• Format – One-on-one investor meetings
• Date and Time – Wednesday, Sept. 16, 2026

A live webcast of the fireside chat will be available on the investor section of the First Tracks website at https://ir.firsttracksbio.com/news-events/events. A replay of the webcast will be available for at least 30 days following the event.

About First Tracks Biotherapeutics

First Tracks Biotherapeutics is a clinical stage biotechnology company advancing antibody therapies that modulate immune pathways implicated in autoimmune and inflammatory diseases. Its pipeline includes ANB033, a CD122 antagonist in development for celiac disease and eosinophilic esophagitis; rosnilimab, a pathogenic T cell depleter in development for rheumatoid arthritis; and ANB101, a BDCA2 modulator. To learn more, visit www.FirstTracksBio.com or follow us on LinkedIn.

Investor Contact:
Nick Montemarano
Vice President, Investor Relations
858.732.0178
investors@firsttracksbio.com

FAQ

When will First Tracks Biotherapeutics (TRAX) present at the 21st Annual Wells Fargo Healthcare Conference?

First Tracks Biotherapeutics will participate in a fireside chat at the 21st Annual Wells Fargo Healthcare Conference on Wednesday, September 9, 2026 at 9:30 a.m. ET / 6:30 a.m. PT, according to the company. The session will also include one-on-one investor meetings.

How can investors listen to the First Tracks Biotherapeutics (TRAX) Wells Fargo fireside chat webcast?

Investors can access a live webcast of the Wells Fargo fireside chat on the investor section of the First Tracks Biotherapeutics website, according to the company. A replay of the webcast will be available for at least 30 days following the event.

What is First Tracks Biotherapeutics doing at Citi's 2026 Biopharma Back to School Conference?

First Tracks Biotherapeutics plans to hold one-on-one investor meetings at Citi's 2026 Biopharma Back to School Conference in New York City on Thursday, September 10, 2026. According to the company, there is no public fireside chat or webcast mentioned for this conference.

When is First Tracks Biotherapeutics attending the Morgan Stanley 24th Annual Global Healthcare Conference?

First Tracks Biotherapeutics is scheduled for one-on-one investor meetings at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on Wednesday, September 16, 2026, according to the company. The announcement does not mention a public webcast for this event.

What types of investor interactions will First Tracks Biotherapeutics (TRAX) have at these September 2026 conferences?

According to First Tracks Biotherapeutics, the company will host a fireside chat plus one-on-one investor meetings at the Wells Fargo Healthcare Conference, and conduct one-on-one investor meetings at both the Citi and Morgan Stanley healthcare conferences.